Flexion Therapeutics Inc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Revenues
Product revenue, net
Operating expenses
Cost of sales
Research and development
General and administrative
Selling, general and administrative
Total operating expenses
Loss from operations

Other (expense) income
Interest income
Interest expense
Other (expense) income
Total other (expense) income
Loss before income taxes
Income tax expense
Net loss
Net loss per common share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Other comprehensive (loss) income
Unrealized (losses) gains from available-for-sale securities, net of tax of $0
Total other comprehensive (loss) income
Comprehensive loss

Comments